Vadim Tsvetnitsky, PhD

Dr. Vadim Tsvetnitsky is an experienced biotechnology professional with more than 21 years of experience developing antibodies and vaccines. Dr. Tsvetnitsky’s particular experience is in leading complex CMC development projects.

After obtaining his undergraduate degree in chemical engineering, Dr. Tsvetnitsky earned his PhD in biochemistry from the University of London School of Pharmacy. He subsequently completed postdoctoral training in protein biochemistry and molecular biology prior to directing multiple product development teams while holding positions of increased responsibility at Cangene, PATH, IAVI, and Codagenix. Dr. Tsvetnitsky has deep expertise in all aspects of CMC, preclinical development, regulatory writing, early-stage clinical trials, and technical operations.